Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Mayo Clinic proceedings

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.mayocp.2014.10.005PMID 25572193PMCID PMC4317334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Net reclassification indices for evaluating risk prediction instruments: a critical review.

  2014cited by this paper
• Utilization of renal mass biopsy in patients with renal cell carcinoma.

  2014cited by this paper
• Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.

  2014cited by this paper
• Evidence of Clinical Utility: An Unmet Need in Molecular Diagnostics for Patients with Cancer

  2014cited by this paper
• Small renal cell carcinomas--how dangerous are they really? Results of a large multicenter study.

  2014cited by this paper
• Role of Percutaneous Needle Biopsy for Renal Masses

  2014cited by this paper
• Percutaneous core biopsy of small renal mass lesions: a diagnostic tool to better stratify patients for surgical intervention

  2013cited by this paper
• A review of contemporary data on surgically resected renal masses--benign or malignant?

  2013cited by this paper
• The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.

  2013cited by this paper
• Prevalence and predictors of benign lesions in renal masses smaller than 7 cm presumed to be renal cell carcinoma.

  2012cited by this paper
• The contemporary role of renal mass biopsy in the management of small renal tumors

  2012cited by this paper
• Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology.

  2012cited by this paper
• Metastatic potential of a renal mass according to original tumour size at presentation

  2012cited by this paper
• Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.

  2011cited by this paper
• Commentary on The R.E.N.A.L. nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth

  2010cited by this paper
• Urinary biomarkers for the early diagnosis of kidney cancer.

  2010cited by this paper
• Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.

  2010cited by this paper
• Accuracy of percutaneous core biopsy in management of small renal masses.

  2009cited by this paper
• Accuracy of Percutaneous Core Biopsy in Management of Small Renal Masses

  2009cited by this paper
• The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth.

  2009cited by this paper
• Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design

  2008cited by this paper
• Renal mass biopsy--a renaissance?

  2008cited by this paper
• Prognostic models and algorithms in renal cell carcinoma.

  2008cited by this paper
• Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival.

  2007cited by this paper
• Second Prize: Frequency of Benign Renal Cortical Tumors and Histologic Subtypes Based on Size in a Contemporary Series: What to Tell our Patients

  2007cited by this paper
• Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists

  2007cited by this paper
• Pathological features of renal neoplasms classified by size and symptomatology.

  2006cited by this paper
• Outcome of renal tumors in young adults.

  2006cited by this paper
• Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging.

  2006cited by this paper
• From the RSNA refresher courses: a practical approach to the cystic renal mass.

  2004cited by this paper
• Solid renal tumors: an analysis of pathological features related to tumor size.

  2003cited by this paper
• Histopathology of surgically managed renal tumors: analysis of a contemporary series.

  2003cited by this paper
• The changing natural history of renal cell carcinoma.

  2001cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.

  1999cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper

• Urine C-reactive protein content and non-invasive molecular grading of renal cell carcinoma.

  2025cites this paper
• Glutathion peroxidase 4 (GPX4) and Ribosomal Protein L40 (RPL40) participate in arsenic induced progression of renal cell carcinoma by regulating the NLRP3 mediated classic pyroptosis pathway.

  2025cites this paper
• The association between serum Perilipin-2 and kidney disease progression of patients with autosomal dominant polycystic kidney disease

  2024cites this paper
• Targeting lipid droplets and lipid droplet-associated proteins: a new perspective on natural compounds against metabolic diseases

  2024cites this paper
• Ameliorative impacts of astaxanthin against atrazine-induced renal toxicity through the modulation of ionic homeostasis and Nrf2 signaling pathways in mice.

  2024cites this paper
• Proteotranscriptomic Discrimination of Tumor and Normal Tissues in Renal Cell Carcinoma

  2023cites this paper
• An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma

  2023cites this paper
• Aquaporins in Urinary System.

  2023cites this paper
• Challenges in Pharmacological Intervention in Perilipins (PLINs) to Modulate Lipid Droplet Dynamics in Obesity and Cancer

  2023cites this paper
• Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease

  2022cites this paper
• PLIN2 promotes HCC cells proliferation by inhibiting the degradation of HIF1α.

  2022cites this paper
• Renal Cell Cancer and Obesity

  2022cites this paper
• Deciphering the Role of Aquaporins in Metabolic Diseases: A Mini Review.

  2022cites this paper
• Identification of Ferroptosis-Related Gene Prognostic Signature and HSF1 for Reversing Doxorubicin and Gemcitabine Resistance in Uterine Carcinosarcoma

  2022cites this paper
• Chromatin regulators-related lncRNA signature predicting the prognosis of kidney renal clear cell carcinoma and its relationship with immune microenvironment: A study based on bioinformatics and experimental validation

  2022influential citation
• Adding fuel to the fire: The lipid droplet and its associated proteins in cancer progression

  2022cites this paper
• Panels of mRNAs and miRNAs for decoding molecular mechanisms of Renal Cell Carcinoma (RCC) subtypes utilizing Artificial Intelligence approaches

  2022cites this paper
• Epidemiology and Prevention of Renal Cell Carcinoma

  2022cites this paper
• Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma

  2022cites this paper
• Mutational Analysis of OCT4+ and OCT4− Circulating Tumour Cells by Single Cell Whole Exome Sequencing in Stage I Non-Small Cell Lung Cancer Patients

  2021cites this paper
• RENAL MASS AND LOCALIZED RENAL CANCER: EVALUATION, MANAGEMENT, AND FOLLOW-UP: AUA GUIDELINE

  2021cites this paper
• Mutational Analysis of OCT4+ and OCT4− Circulating Tumour Cells by Single Cell Whole Exome Sequencing in Stage I Non-Small Cell Lung Cancer Patients

  2021cites this paper
• BRIEF Urinary Human Kidney Injury Molecule1- (hKIM1-) is not Increased in Patients with Renal Cell Carcinoma

  2021cites this paper
• Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy

  2021cites this paper
• Serum Perilipin 2 (PLIN2) Predicts Multiple Organ Dysfunction in Critically Ill Patients

  2021cites this paper
• Perilipin 2 Impacts Acute Kidney Injury via Regulation of PPARα

  2021cites this paper
• Decision-making in active surveillance in kidney cancer: current trends and future urine and tissue markers

  2021cites this paper
• Circulating perilipin 2 levels are associated with fat mass, inflammatory and metabolic markers and are higher in women than men

  2021cites this paper
• Diagnostic accuracy of urinary aquaporin-1 as a biomarker for renal cell carcinoma

  2021cites this paper
• Update on urine as a biomarker in cancer: a necessary review of an old story

  2020cites this paper
• Combined Systematic Review and Transcriptomic Analyses of Mammalian Aquaporin Classes 1 to 10 as Biomarkers and Prognostic Indicators in Diverse Cancers

  2020cites this paper
• Review: Detection and quantification of proteins in human urine

  2020cites this paper
• MicroRNA Signature in Renal Cell Carcinoma

  2020cites this paper
• ADFP promotes cell proliferation in lung adenocarcinoma via Akt phosphorylation

  2020cites this paper
• Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study

  2020cites this paper
• Running head: Urinary hKIM-1 in RCC – Białek et al. Urinary Human Kidney Injury Molecule-1 (hKIM-1) Is Not Increased in Patients with Renal Cell Carcinoma

  2020cites this paper
• Renal Cell Carcinoma Biomarkers in Proximal Fluids

  2019cites this paper
• Aquaporins 1, 3 and 5 in Different Tumors, their Expression, Prognosis Value and Role as New Therapeutic Targets

  2019cites this paper
• Bioplasmonic paper-based assay for perilipin-2 non-invasively detects renal cancer.

  2019cites this paper
• Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma

  2019cites this paper
• Integrated Molecular Analysis for the Identification and Validation of Novel Biomarkers for Renal Cell Carcinoma and the Small Renal Mass

  2019cites this paper
• Aquaporins in Renal Diseases

  2019cites this paper
• Epidemiology of Renal Cell Carcinoma.

  2019cites this paper
• The use of TAP for the primary diagnosis of renal cell carcinoma

  2019cites this paper
• Platinum Priority – Review – Kidney Cancer

  2018cites this paper
• Genitourinary Cancers

  2018cites this paper
• Effect of selective inhibition of aquaporin 1 on chemotherapy sensitivity of J82 human bladder cancer cells.

  2018cites this paper
• Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?

  2018cites this paper
• Plasma Glycosaminoglycans as Diagnostic and Prognostic Biomarkers in Surgically Treated Renal Cell Carcinoma

  2018cites this paper
• Epidemiology and screening for renal cancer

  2018cites this paper
• Aquaporin–graphene interface: relevance to point-of-care device for renal cell carcinoma and desalination

  2018cites this paper
• Management of Small Renal Masses.

  2018cites this paper
• Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma

  2018cites this paper
• Aquaporins in Urinary System.

  2017cites this paper
• Renal cell carcinoma: a critical analysis of metabolomic biomarkers emerging from current model systems

  2017cites this paper
• Biomarkers of Renal Cancer

  2017cites this paper
• Data‐Independent Acquisition‐Based Quantitative Proteomic Analysis Reveals Potential Biomarkers of Kidney Cancer

  2017cites this paper
• The kidney cancer research priority-setting partnership: Identifying the top 10 research priorities as defined by patients, caregivers, and expert clinicians.

  2017cites this paper
• Should Small Renal Masses Be Biopsied?

  2017cites this paper
• Setting Research Priorities for Kidney Cancer.

  2017cites this paper
• Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.

  2017cites this paper
• Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes

  2017cites this paper
• Liquid biopsy: a step forward towards precision medicine in urologic malignancies

  2017cites this paper
• A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses.

  2016cites this paper
• Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta‐analysis of clinically localized renal masses suspicious for malignancy

  2016cites this paper
• Perilipin 2 and Age-Related Metabolic Diseases: A New Perspective.

  2016cites this paper
• Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.

  2015cites this paper
• Expression of aquaporin 1 in bladder uroepithelial cell carcinoma and its relevance to recurrence.

  2015cites this paper
• The Past, Present, and Future in Management of Small Renal Masses

  2015cites this paper
• Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.

  2015cites this paper
• Indications for biopsy and the current status of focal therapy for renal tumours

  2015cites this paper
• Through a Clear Cell, Darkly: HIF2α/PLIN2-Maintained Fat Droplets Protect ccRCCs from ER Stress.

  2015cites this paper
• Overexpression of PLIN 2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma

  year unknowncites this paper